Direct molecular versus culture-based assessment of Gram-positive cocci in biopsies of patients with major abscesses and diabetic foot infections by Stappers, M.H.T. (Mark H. T.) et al.
ARTICLE
Direct molecular versus culture-based
assessment of Gram-positive cocci in biopsies of patients
with major abscesses and diabetic foot infections
M. H. T. Stappers1,2,3 & F. Hagen2 & P. Reimnitz4 & J. W. Mouton5,6 & J. F. Meis2,5,6 &
I. C. Gyssens1,2,3
Received: 20 May 2015 /Accepted: 11 June 2015 /Published online: 5 July 2015
# The Author(s) 2015. This article is published with open access at Springerlink.com
Abstract Major abscesses and diabetic foot infections (DFIs)
are predominant subtypes of complicated skin and skin struc-
ture infections (cSSSIs), and are mainly caused by
Staphylococcus aureus and β-hemolytic streptococci. This
study evaluates the potential benefit of direct pathogen-
specific real-time polymerase chain reaction (PCR) assays in
the identification of causative organisms of cSSSIs. One-
hundred and fifty major abscess and 128 DFI biopsy samples
were collected and microbial DNAwas extracted by using the
Universal Microbe Detection kit for tissue samples. Pathogen-
specific PCRs were developed for S. aureus and its virulence
factor Panton–Valentine leukocidin (PVL), Streptococcus
pyogenes , S. agalactiae , S. dysgalactiae , and the
S. anginosus group. Identification by pathogen-specific
PCRs was compared to routine culture and bothmethods were
considered as the gold standard for determination of the sen-
sitivity and specificity of each assay. Direct real-time PCR
assays of biopsy samples resulted in a 34 % higher detection
of S. aureus, 37 % higher detection of S. pyogenes, 18 %
higher detection of S. agalactiae, 4 % higher detection of
S. dysgalactiae subspecies equisimilis, and 7 % higher detec-
tion of the S. anginosus group, compared to routine bacterial
culture. The presence of PVL was mainly confined to
S. aureus isolated from major abscess but not DFI biopsy
samples. In conclusion, our pathogen-specific real-time PCR
assays had a higher yield than culture methods and could be an
additional method for the detection of relevant causative path-
ogens in biopsies.
Introduction
Major abscesses and diabetic foot infections (DFIs) are the
predominant subtypes of a spectrum of infections termed
complicated skin and skin structure infections (cSSSIs). The
Food and Drug Administration (FDA) defined cSSSIs as in-
fections of the deeper soft tissues, involving surgical interven-
tion or a significant underlying disease state that complicates
the response to treatment. Superficial infections located in an
anatomical site in which the chance of involvement of anaer-
obic or Gram-negative pathogens is high should also be con-
sidered as cSSSIs [1, 2]. cSSSIs are associated with significant
morbidity and mortality, as well as prolonged and expensive
hospitalizations [3]. The management of cSSSIs involves sur-
gical debridement of the infection, combined with antibiotic
therapy [4].
Gram-positive cocci, in particular Staphylococcus aureus
andβ-hemolytic streptococci, are the leading causative organ-
isms of cSSSIs [2, 4]. In a recent multicenter randomized
clinical trial, 65 % of the cultured isolates consisted of
Gram-positive cocci (S. aureus 33 % and β-hemolytic strep-
tococci 15 %), whereas Gram-negative bacilli (28 %) and
anaerobes (7 %) were found to a lesser extent [5], but geo-
graphical differences exist in the type and amount of species
isolated [6]. Correct and rapid identification of pathogens is
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crucial for clinical decision-making and optimal antibiotic
therapy. Up to now, routine bacteriological assessment of bi-
opsies from cSSSIs relies upon culture, which, in order to be
successful, requires viable pathogens in tissue and the use of
suitable culture conditions for growth. Difficult to culture
pathogens, those present in low numbers or that died before/
during sampling of the infected tissue make detection by cul-
ture complicated and time-consuming. This may result in low
sensitivity and underestimated bacterial prevalence. Several
molecular assays, such as pathogen-specific, broad-range,
and multiplex polymerase chain reaction (PCR) assays, either
directly on clinical samples or cultured isolates, have been
developed in recent years to improve bacteriological detection
[7, 8]. This study evaluates the potential benefit of direct,
pathogen-specific real-time PCR assays on clinical samples
in the identification of the causative organisms of cSSSIs.
Biopsy samples of 150 major abscesses and 128 DFIs were
collected during a multicenter clinical trial involving patients
with cSSSIs [5]. Detection of the pathogens S. aureus and
Streptococcus species by real-time PCR directly on DNA iso-
lated from these clinical cSSSI samples was compared to rou-
tine cultures.
Materials and methods
Definitions
cSSSIs were characterized as infections of bacterial origin that
required hospitalization, initial parenteral therapy for ≥48 h,
and which met at least one of the following criteria: deep soft
tissue involvement; significant surgical intervention, includ-
ing drainage and/or debridement; and association with an un-
derlying comorbid condition.Major abscesses were defined as
collections of pus associated with extensive cellulitis, requir-
ing surgical intervention followed by antibiotic therapy. DFIs
were characterized as infections occurring below the ankle in
patients with confirmed diabetes [5].
Collection of major abscess and DFI biopsy samples
From a population of 813 cSSSI patients included in a large
randomized, multicenter clinical trial [5], performed from
September 2006 to June 2008, 389 patients gave informed
consent to participate in this substudy. Of these, the first visit,
prestudy treatment biopsy samples were selected, resulting in
the inclusion of 150 major abscess and 128 DFI samples from
225 cSSSI patients. Samples were collected via biopsy of
tissue or bone, curettage of the wound, or aspiration of puru-
lent discharge. After collection, samples were directly stored
in preservation medium (BBL Port-A-Cul Transport vial,
Becton Dickinson, Franklin Lakes, NJ, USA) and transported
within 72 h to the central laboratory (Eurofins Medinet SAS,
Plaisir, France) [5]. On arrival, samples were split into two,
one part for immediate culture and identification by using
standard clinical laboratory procedures, and the other part
was stored at −80 °C for subsequent DNA isolation and
PCR analysis.
Bacterial DNA extraction from biopsy samples
Pathogen DNAwas manually extracted by using the MolYsis
Universal Microbial Detection kit for tissue samples
(Molzym, Bremen, Germany), following the manufacturer’s
instructions. Briefly, selective lysis of human cells is per-
formed, followed by degradation of human DNA. After wash-
ing the pellet, a second round of DNA extraction is performed
to release DNA from bacterial and fungal cells. This approach
enables an increased sensitivity and specificity for pathogen
DNA, since interfering non-target human DNA is no longer
present [9]. Pathogen DNA extraction was carried out in a
laminar flow cabinet to prevent contamination. Prior to further
handling, the DNA samples were stored at −20 °C.
Real-time PCR primer and probe design
To detect S. agalactiae, in both subspecies of S. dysgalactiae
and S. pyogenes, the recA gene was chosen as the target, based
on the results from previous studies [10, 11]. Partial recA
sequences of clinically relevant Streptococcus species were
extracted from GenBank (accession numbers EU156792–
EU156872), an alignment was generated in MEGA v6 [12],
and primer and probe sets were developed to make sure that
there was no overlap with other Streptococcus species. The
specificity of the primers and probes were in silico tested by a
BLAST search in GenBank.
A previously described multiplex real-time PCR assay was
used to detect the S. aureus-specific fragment Sa442 and the
Panton–Valentine leukocidin (PVL) gene [13].
The duplex real-time PCRs were performed in reaction
volumes of 20 μL consisting of 10 μL 2× LC480 Probe
Master Mix (Roche Diagnostics), 0.1 μL of each primer and
0.04 μL of both probes (100pmol/μL; Eurogentec, Brussels,
Belgium), 1.72 μL ddH2O, and 8 μL sample DNA. The PCRs
were performed with the following settings: initial denatur-
ation step for 10 min at 95 °C, 50 cycles of 1 s at 95 °C,
12 s at 60 °C, followed by measuring the fluorescence signal,
and a cooldown step for 30s at 40 °C.
For detection of members of the S. anginosus group
(S. anginosus, S. constellatus, and S. intermedius, also termed
the S. milleri group), a set of primers was developed based on
an alignment made in MEGA v6 of the recN sequences
EU917226–EU917315 [12, 14]. The PCRs were performed
in 10 μL reaction volumes, containing 5 μL 2× LC480 Probe
Master Mix (Roche Diagnostics, Almere, the Netherlands),
0.5 μL of each primer (10pmol/μL; Eurogentec), 0.5 μL
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SYTO82 (40 μM; Molecular Probes, Eugene, OR,
USA), 2.5 μL ddH2O, and 1 μL sample DNA. The
following PCR program was used: initial denaturation
for 10 min at 95 °C, 35 cycles of 5 s at 95 °C, 5 s
at 60 °C, and 10 s at 72 °C, followed by a melting
curve analysis at 65 °C to 95 °C. Fluorescence was
measured after each extension step.
The primer and probe sequences of all assays are provided
in Table 1.
Real-time PCR assays and analysis
The analytic specificity was tested by applying the newly
developed Streptococcus assays on a set of 62 clinically rele-
vant Streptococcus reference strains. The sensitivity of the
Streptococcus assays was performed by applying two-step
dilution series of the relevant type strains, starting with an
input ranging from 0.01 ng to 4.9 fg per reaction. The equiv-
alent of genomic copies per reaction was calculated based on
the genome sizes for each of the Streptococcus species [15,
16].
Statistical analysis
McNemar’s test was performed to study differences between
real-time PCR and culture-based assessment of pathogenic
presence, for major abscesses and DFIs separately. The results
for major abscesses and DFIs were combined for the determi-
nation of the sensitivity, specificity, positive predictive value
(PPV), and negative predictive value (NPV). Both culture and
real-time PCR were considered as the gold standard.
Results
Validation of species-specific Streptococcus real-time PCR
assays and analysis
The S. agalactiae real-time PCR assay was found to be posi-
tive for the included strains; however, atypical amplification
curves were observed for twoS. anginosus strains. The
S. pyogenes assay, included in the duplex real-time PCR with
S. agalactiae, was found to be exclusively positive for strains
that belong to this species. The S. dysgalactiae duplex real-
time PCR assay was positive for the included subspecies
dysgalactiae and equisimilis. However, the assay for subspe-
cies equisimilis showed an atypical amplification curve for
one strain of S. constellatus and S. cristatus.
The lower limit of detection was found to be at the 9th
dilution step for the targets S. agalactiae, both subspecies of
S. dysgalactiae and S. pyogenes, equivalent of ~39 fg DNA
per reaction, equal to ~17 genomic copies per reaction. For the
intercalating dye-based assay for S. anginosus, S. constellatus
and S. intermedius assay, the lower limit of detection was
found to be at the 8th dilution step, equal to 78 fg or ~37
genomic copies per reaction.
Real-time PCR versus culture-based assessment
of S. aureus prevalence in major abscesses and DFIs
The first visit biopsy samples of 150 major abscesses and 128
DFIs were collected, and the identification of S. aureus was
performed by real-time PCR and culture. Of the 150 major
abscess samples, 81%were positive for S. aureus by real-time
PCR, whereas 44 % were culture-positive for S. aureus. None
of the culture-positive samples were real-time PCR-negative
(Table 2). Of the 128 DFI samples, 88 % were positive for
S. aureus by real-time PCR, whereas 57 % were culture-
positive for S. aureus. One culture-positive sample was found
to be real-time PCR-negative (Table 2). Subsequent real-time
PCR determination of the cultured strain from the culture-
positive, real-time PCR-negative biopsy sample confirmed
the presence of S. aureus. Statistical analysis using
McNemar’s test showed a significant difference between
S. aureus real-time PCR and culture-based assessment for
Table 1 Primer and probe sequences
Specificity Forward primer Probe Reverse primer
S. aureus* 5’-ACGA
CTARATAA
ACGCTCAT
TCG-3’
5’-HEX-TGAAAT
CTCATTACGT
TGCATCGGA-
BHQ1-3’
5’-GACGGC
TTTTACAT
ACAGAA
CACA-3’
PVL* 5’-AAAAAG
GCTCAG
GAGATA
CAAGTG -
3’
5’-Cy5-TGGCAG
AAATATGGAT
GTTACTCATG
C-BHQ2-3’
5’-TGCCAT
AGTGTG
TTGTTCTT
CTAGT-3’
S. pyogenes 5’-TTGGAA
ACGATA
GCTAATAC
CG-3’
5’-HEX-CGCATG
TTAGTAATTT
AAAAGGGGCA
-BHQ1-3’
5’-CGCAGG
TCCATC
TCATAG
TG-3’
S. agalactiae 5’-FAM-TGTTAG
TTATTTAAAA
GGAGCAATTG
C-BHQ1-3’
S.dysgalactiae
equisimilis
5’-HEX-CCCATG
TTAAACATTT
AAAAGGTGCA
-BHQ1-3’
S.dysgalactiae
dysgalacti-
ae
5’-FAM-AATGGA
GGACCCATGT
CTTTCATTT-
BHQ1-3’
S. anginosus
group
5’-TGGACA
GCATTTGG
TGGATA-3’
n/a 5’-GCTTAC
GCAACT
GACGAT
ACTG-3’
*This assay was previously published by Hopman et al. [13]
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major abscesses (p<0.001) and DFIs (p<0.001). The sensitiv-
ity, specificity, PPV, and NPV for the S. aureus real-time PCR
and culture are shown in Table 3.
Real-time PCR-based assessment of PVL versus S. aureus
prevalence in major abscesses and DFIs
The presence of S. aureus virulence factor PVL was deter-
mined by real-time PCR and correlated to S. aureus real-
time PCR-positive biopsies. Of interest, the majority of
S. aureus real-time PCR-positive major abscess samples were
also PVL real-time PCR-positive (89 %). In contrast, a minor-
ity of S. aureus real-time PCR-positive DFI samples were
PVL real-time PCR-positive (14 %). In both groups of major
abscesses and DFIs, two samples were PVL real-time PCR-
positive but not S. aureus real-time PCR-positive (Table 4).
Real-time PCR versus culture-based assessment
of S. pyogenes prevalence in major abscesses and DFIs
Of the 150 major abscess samples, 85 % were positive for
S. pyogenes by real-time PCR, whereas 15 % were culture-
positive for S. pyogenes. None of the culture-positive samples
were real-time PCR-negative (Table 2). Of the 128 DFI sam-
ples, 15 % were positive for S. pyogenes by real-time PCR,
whereas 1 % were culture-positive for S. pyogenes. The only
culture-positive sample was also real-time PCR-positive
(Table 2). Statistical analysis showed a significant difference
between S. pyogenes real-time PCR and culture-based assess-
ment for major abscesses (p<0.001) and DFIs (p<0.001). The
sensitivity, specificity, PPV, and NPV for the S. pyogenes real-
time PCR and culture are shown in Table 3.
Real-time PCR versus culture-based assessment
of S. agalactiae prevalence in major abscesses and DFIs
Of the 150 major abscess samples, 31 % were positive for
S. agalactiae by real-time PCR, whereas 5 % were culture-
positive for S. agalactiae. Three culture-positive samples were
real-time PCR-negative (Table 2). Of the 128 DFI samples,
30%were positive for S. agalactiae by real-time PCR, where-
as 22 % were culture-positive for S. agalactiae. Ten culture-
positive samples were real-time PCR-negative (Table 2).
Subsequent real-time PCR determination of the cultured
Table 2 Real-time polymerase chain reaction (real-time PCR) versus culture-based assessment of Gram-positive coccal prevalence in major abscesses
and diabetic foot infections
Major abscesses Diabetic foot infections
Real-time
PCR-positive
Real-time
PCR-negative
Total Real-time
PCR-positive
Real-time
PCR-negative
Total
S. aureus
Culture-positive 66 0 66 Culture-positive 72 1 73
Culture-negative 55 29 84 Culture-negative 41 14 55
Total 121 29 150 Total 113 15 128
S. pyogenes
Culture-positive 23 0 23 Culture-positive 1 0 1
Culture-negative 104 23 127 Culture-negative 18 109 127
Total 127 23 150 Total 19 109 128
S. agalactiae
Culture-positive 5 3 8 Culture-positive 18 10 28
Culture-negative 42 100 142 Culture-negative 21 79 100
Total 47 103 150 Total 39 89 128
S. dysgalactiae subspecies equisimilis
Culture-positive 3 1 4 Culture-positive 16 1 17
Culture-negative 0 146 146 Culture-negative 12 99 111
Total 3 147 150 Total 28 100 128
S. anginosus group
Culture-positive 16 7 23 Culture-positive 6 1 7
Culture-negative 13 114 127 Culture-negative 13 108 121
Total 29 121 150 Total 19 109 128
1888 Eur J Clin Microbiol Infect Dis (2015) 34:1885–1892
strains from the 13 culture-positive, real-time PCR-negative
biopsy samples confirmed the presence of S. agalactiae of four
strains. The other nine strains were negative for S. agalactiae
real-time PCR. Statistical analysis showed a significant differ-
ence between S. agalactiae real-time PCR and culture-based
assessment for major abscesses (p<0.001) but not DFIs
(p>0.05). The sensitivity, specificity, PPV, and NPV for the
S. agalactiae real-time PCR and culture are shown in Table 3.
Real-time PCR versus culture-based assessment
of S. dysgalactiae prevalence in major abscesses and DFIs
Of the 150 major abscess samples, 2 % were positive for
S. dysgalactiae subspecies equisimilis by real-time PCR, whereas
3 % were culture-positive for S. dysgalactiae subspecies
equisimilis. One of the culture-positive samples was real-time
PCR-negative (Table 2). Of the 128 DFI samples, 22 % were
positive for S. dysgalactiae subspecies equisimilis by real-time
PCR, whereas 13%were culture-positive for S. dysgalactiae sub-
species equisimilis. One DFI sample was found to be culture-
positive but real-time PCR-negative (Table 2). Subsequent
real-time PCR determination of the cultured strains from the two
culture-positive, real-time PCR-negative biopsy samples
confirmed the presence of S. dysgalactiae subspecies equisimilis
of one strain. The other strain was negative for S. dysgalactiae
subspecies equisimilis real-time PCR. Statistical analysis showed
a significant difference between S. dysgalactiae subspecies
equisimilis real-time PCR and culture-based assessment for DFIs
(p<0.01) but not major abscesses (p>0.05). The sensitivity,
specificity, PPV, and NPV for the S. dysgalactiae subspecies
equisimilis real-time PCR and culture are shown in Table 3.
None of the 150 major abscess samples were real-time
PCR or culture positive for S. dysgalactiae subspecies
dysgalactiae. Of the 128 DFI samples, only one sample was
positive for S. dysgalactiae subspecies dysgalactiae by real-
time PCR but culture-negative, and, also, one sample was
culture-positive for S. dysgalactiae subspecies dysgalactiae
but real-time PCR-negative. Subsequent real-time PCR deter-
mination of the cultured strain from the culture-positive, real-
time PCR-negative biopsy sample was negative for
S. dysgalactiae subspecies dysgalactiae but positive for
S. dysgalactiae subspecies equisimilis.
Real-time PCR versus culture-based assessment
of S. anginosus group prevalence in major abscesses
and DFIs
S. anginosus, S. constellatus, and S. intermedius together con-
stitute the S. anginosus group. Of the 150 major abscess sam-
ples, 19 % were positive for members of the S. anginosus
Table 3 Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of real-time polymerase chain reaction (real-time
PCR) and culture-based assessment of Gram-positive coccal prevalence in major abscesses and diabetic foot infections
Species Reference Assay Sensitivity (%) Specificity (%) PPV (%) NPV (%)
S. aureus Culture Real-time PCR 99 31 59 98
Real-time PCR Culture 59 98 99 31
S. pyogenes Culture Real-time PCR 100 86 16 100
Real-time PCR Culture 16 100 100 86
S. agalactiae Culture Real-time PCR 64 74 27 93
Real-time PCR Culture 27 93 64 74
S. dysgalactiae equisimilis Culture Real-time PCR 91 95 61 99
Real-time PCR Culture 61 99 91 95
S. anginosus group Culture Real-time PCR 73 90 46 97
Real-time PCR Culture 46 97 73 90
Table 4 Real-time polymerase chain reaction (real-time PCR)-based assessment of Panton–Valentine leukocidin (PVL) versus Staphylococcus aureus
prevalence in major abscesses and diabetic foot infections
Major abscesses Diabetic foot infections
S. aureus real-time
PCR-positive
S. aureus real-time
PCR-negative
Total S. aureus real-time
PCR-positive
S. aureus real-time
PCR-negative
Total
PVL real-time
PCR-positive
108 2 110 PVL real-time
PCR-positive
16 2 18
PVL real-time
PCR-negative
13 27 40 PVL real-time
PCR-negative
97 13 110
Total 121 29 150 Total 113 15 128
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group by real-time PCR, whereas 15 % were culture-positive
for members of the S. anginosus group. Seven culture-positive
samples were real-time PCR-negative (Table 2). Of the 128
DFI samples, 15 % were positive for members of the
S. anginosus group by real-time PCR, whereas 6 % were
culture-positive for members of the S. anginosus group. One
culture-positive sample was real-time PCR-negative (Table 2).
Subsequent real-time PCR determination of the cultured
strains from the eight culture-positive, real-time PCR-negative
biopsy samples confirmed identification of the S. anginosus
group of six strains. Of the two other strains, one was negative
for S. anginosus group real-time PCR and the other strain was
not viable. Statistical analysis showed a significant difference
between S. anginosus group real-time PCR and culture-based
assessment for DFIs (p<0.01) but not major abscesses
(p>0.05). The sensitivity, specificity, PPV, and NPV for the
S. anginosus group real-time PCR and culture are shown in
Table 3.
Discussion
This study is the first to demonstrate that the use of direct real-
time PCR versus culture-based assessment for the determina-
tion of pathogens in clinical biopsy samples of patients with
major abscesses and DFIs resulted in an increased detection of
all studied cSSSI pathogens: S. aureus, S. pyogenes,
S. agalactiae, S. dysgalactiae, and S. anginosus group.
The current routine practice for the detection and identifi-
cation of bacterial pathogens in cSSSI is culture of biopsy
samples collected from the site of infection. Development of
direct real-time PCR assays on bacterial DNA isolated from
biopsy samples resulted in a higher detection of 34 % for
S. aureus, 37 % for S. pyogenes, 18 % for S. agalactiae,
4 % for S. dysgalactiae subspecies equisimilis, and 7 % for
the S. anginosus group compared to standard cultures. No
differences were observed for S. dysgalactiae subspecies
dysgalactiae, which could be due to its low prevalence in
human infections [17]. Significant differences were found be-
tween real-time PCR and culture assessment for S. aureus
(major abscesses and DFIs), S. pyogenes (major abscesses
and DFIs), S. agalactiae (major abscesses), S. dysgalactiae
subspecies equisimilis (DFIs), and S. anginosus group
(DFIs). Possible explanations for the real-time PCR-positive,
culture-negative biopsy samples are: culture is less sensitive
than real-time PCR for the detection of organisms, real-time
PCR detects nonviable organisms in contrast to culture, split-
ting of the biopsy sample into two parts for culture and real-
time PCR, contamination of the real-time PCR reagents,
cross-reactivity of the real-time PCR assay with DNA from
other organisms or human origin not controlled for during the
development of the assay inducing false-positives.
In contrast, our real-time PCR assays did not identify some
pathogens that were grown in culture. Possible explanations
for the culture-positive, real-time PCR-negative biopsy sam-
ples are: real-time PCR is less sensitive than culture for the
detection of organisms, incorrect determination during cul-
ture, low prevalence of bacterial DNA in the biopsy sample,
splitting of the biopsy sample into two parts for culture
and real-time PCR, low DNA yield or poor quality
DNA after extraction or the presence of factors that
inhibit the real-time PCR assay, poor target specificity,
and/or competition between primers and probes within
the developed real-time PCR not controlled for during
the development of the assay.
Other studies evaluating the potential of direct real-time
PCR in the detection of the organisms studied here frequently
found comparable or increased detection rates compared to
culture methods. The detection of (methicillin-resistant)
S. aureus by real-time PCR was similar to culture in samples
from skin and soft tissue infections and osteoarticular infec-
tions [18, 19], and increased in a screening for MRSA colo-
nization [20]. In addition, the detection of S. pyogenes by real-
time PCR was similar to culture in throat swabs from
suspected pharyngitis [21, 22]. Furthermore, similar and in-
creased detection rates of S. agalactiae were found in screen-
ing samples of vaginal and neonatal colonization [23–25], and
increased detection was observed by real-time PCR for
S. agalactiae in cerebrospinal fluid and blood from patients
suspected of meningitis and sepsis [26].
Overall, combined detection by either culture and/or real-
time PCR resulted in 85 % of samples positive for S. aureus,
68 % positive for S. pyogenes, 36 % positive for S. agalactiae,
12 % positive for S. dysgalactiae subspecies equisimilis,
0.7 % positive for S. dysgalactiae subspecies dysgalactiae,
and 20 % positive for S. anginosus group. This again under-
lines the importance of Gram-positive cocci in cSSSIs.
Interestingly, there are differences in the species present in
major abscesses and DFIs. S. pyogenes was mainly detected
in biopsies from major abscesses, whereas S. dysgalactiae
subspecies equisimilis was mainly found in biopsies from di-
abetic foot infections. Other identified pathogens were simi-
larly present in both major abscesses and DFIs. In addition, a
clear distinction was observed between major abscesses and
DFIs for PVL-positive S. aureus. 73% of the major abscesses,
but only 14% of the DFIs, were positive for PVL. PVL is a bi-
component pore-forming toxin, encoded by the lukS-PV and
lukF-PV genes, and is associated with lysis of leukocytes [27].
A recent meta-analysis confirmed the association between
PVL and S. aureus skin and skin structure infections, which
was not present for S. aureus invasive infections, such as
pneumonia, musculoskeletal infections, and bacteremia [28].
In an attempt to evaluate the reliability of the real-time PCR
and culture, we have calculated the sensitivity, specificity,
PPV, and NPV. Both techniques were separately considered
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as the gold standard, as it is unknown which technique repre-
sents the Btrue^ presence of pathogens in the biopsy samples.
In conclusion, current routine bacteriological assessment of
biopsies by culture is time-consuming, requires viable patho-
gens, culture conditions suitable for growth, and results in
lower detection sensitivity and may underestimate bacterial
prevalence. However, given the fast and superior detection
of cSSSI pathogens by real-time PCR, our study indicates that
molecular analysis can be an additional method for the detec-
tion of bacteria in clinical samples.
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